PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology, ASST Spedali Civili, Brescia, Italy. chiara.cattaneo@asst-spedalicivili.it.\', \'Hematology, ASST Spedali Civili, Brescia, Italy.\', \'CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.\', \'Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.\', \'National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.\', \'Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41408-021-00546-9
?:hasPublicationType
?:journal
  • Blood cancer journal
is ?:pmid of
?:pmid
?:pmid
  • 34521813
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.727
?:rankingScore_hIndex
  • 30
is ?:relation_isRelatedTo_publication of
?:title
  • Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34521813>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34521813>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all